GLP-1 Side Effects Your CGM Notices Before You Do
“Education is not a part of the treatment of diabetes”
A CGM often shows a GLP-1's effects before you consciously feel them — flatter post-meal curves, lower overnight glucose, and the downstream marks of slowed digestion and smaller meals. It reflects what's happening, but it doesn't diagnose side effects on its own.
A continuous glucose monitor watches your body around the clock, which means it sometimes registers changes before you'd notice them yourself. On a GLP-1, a few patterns tend to show up on the sensor early, and knowing what they mean helps you read your own data instead of worrying about it.
Flatter post-meal peaks: the drug working
The first thing many people see is that their after-meal spikes get smaller and rounder. That's the core effect of the drug, coming from slowed stomach emptying and better-timed insulin (Thomas 2023). If your curves are flattening within the first weeks, that's a good sign the GLP-1 is doing its job, and you may see it on the graph before you feel any different.
The fingerprint of eating less
Because a GLP-1 cuts appetite, your eating pattern changes, and the sensor picks that up too. Smaller meals mean smaller rises. Skipped snacks show as long flat stretches. A lower overall glucose average often follows simply because you're eating less. None of this is a side effect exactly, but it's the drug's ripple effects made visible.
Where a CGM hints at the gut effects
The most common GLP-1 side effects are digestive: nausea, fullness, slowed digestion. A CGM doesn't measure nausea, but slowed gastric emptying can change the shape of your post-meal curve, sometimes delaying or blunting the usual rise. If your curves look unusually flat and you also feel queasy or overly full, those two things are related, both tracing back to how the drug slows your gut.
The lows worth catching early
If you take insulin or a sulfonylurea alongside a GLP-1, the sensor's most valuable early catch is a downward drift into lows. Time below range creeping up on your CGM is an early signal that those other medications may need adjusting, often before you feel a single symptom. This is the one pattern worth acting on promptly with your clinician.
What the CGM can't tell you
A sensor shows correlations, not diagnoses. It can show a flat, odd curve alongside your nausea, but it can't tell you a side effect is or isn't serious. Use it as an early-warning and pattern tool, and bring what you see to your clinician rather than self-diagnosing from the graph.
Catch the early signals, skip the noise
Most of what a CGM shows in the first weeks is reassuring once you know how to read it. Endobits flags the patterns that actually matter — the flattening that means it's working, the drift that means check in — so the early signals reach you without the noise. Start with Endobits →
Sources
- Thomas MC, Coughlan MT, Cooper ME. The postprandial actions of GLP-1 receptor agonists. Cell Metabolism, 2023. 10.1016/j.cmet.2023.01.004